0001209191-16-136329.txt : 20160810 0001209191-16-136329.hdr.sgml : 20160810 20160810164343 ACCESSION NUMBER: 0001209191-16-136329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160809 FILED AS OF DATE: 20160810 DATE AS OF CHANGE: 20160810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Epizyme, Inc. CENTRAL INDEX KEY: 0001571498 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261349956 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-229-5872 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singer Andrew E. CENTRAL INDEX KEY: 0001632720 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35945 FILM NUMBER: 161821982 MAIL ADDRESS: STREET 1: C/O EPIZYME, INC. STREET 2: 400 TECHNOLOGY SQUARE, 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-09 0 0001571498 Epizyme, Inc. EPZM 0001632720 Singer Andrew E. C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 0 1 0 0 EVP & CFO Common Stock, par value $0.0001 2016-08-09 4 M 0 1682 A 26274 D Common Stock, par value $0.0001 2016-08-09 4 M 0 778 A 27052 D Common Stock, par value $0.0001 2016-08-09 4 S 0 1013 9.0479 D 26039 D Restricted Stock Units 2016-08-09 4 M 0 1682 0.00 D Common Stock 1682 50457 D Restricted Stock Units 2016-08-09 4 M 0 778 0.00 D Common Stock 778 23320 D Each restricted stock unit represents the contingent right to receive one share of Epizyme, Inc. common stock upon vesting. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person to cover taxes associated with the vesting of his restricted stock. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.01 per share to $9.29 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This award, granted on February 9, 2016, pursuant to the reporting person's employment agreement, dated January 23,2015, vests as to 25% of the total award on February 9, 2016, a year from the commencement of employment, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person. This award, granted on February 9, 2015, pursuant to the Company's 2013 Stock Inventive Plan, vests as to 25% of the total award on February 9, 2016, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person. /s/ Adriana Sullivan, attorney-in-fact 2016-08-10